ESPEL
ActiveSummary
ESPEL has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €205,262 and a net result of €400. Equity remains stable across the filed financial years (±2.3% per year). Its solvency ranks better than 45% of 925 sector peers (NACE 56, financial year 2025). The computed 12-month bankruptcy probability is 1.4% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2025
23-10
NBB filing
Annual accounts filed
financial year 2025 · full format
2024
24-10
NBB filing
Annual accounts filed
financial year 2024 · full format
2023
23-10
NBB filing
Annual accounts filed
financial year 2023 · full format
2022
26-10
NBB filing
Annual accounts filed
financial year 2022 · full format
31-03
Financial
Equity above €200,000equity €203,215 ▲2.3%
2 profitable years in a row build equity to €203,215.
2021
28-10
NBB filing
Annual accounts filed
financial year 2021 · full format
31-03
Financial
Back to profitnet €104,708
Net result €104,708 after one loss-making year.
31-03
Financial
Equity above €150,000equity €198,578 ▲112%
Equity rises from €93,870 to €198,578.
2020
29-10
NBB filing
Annual accounts filed
financial year 2020 · full format
31-03
Financial
Weakest financial yearnet -€38,849
Net result drops to -€38,849, the lowest in the series; recovery starts the following year.
2019
10-10
NBB filing
Annual accounts filed
financial year 2019 · full format
2018
19-10
NBB filing
Annual accounts filed
financial year 2018 · full format
2017
05-10
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2016
11-10
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 20 annual accounts filed, the latest 10 are here; all 20 are under Financials.
0 of 4 deeds read
About the unread acts
We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.